Filing Details
- Accession Number:
- 0001144204-14-060879
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-14 12:09:55
- Reporting Period:
- 2014-10-09
- Filing Date:
- 2014-10-14
- Accepted Time:
- 2014-10-14 12:09:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 910267 | Titan Pharmaceuticals Inc | TTNP.OB | Biological Products, (No Disgnostic Substances) (2836) | 943171940 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1180755 | Sunil Bhonsle | 400 Oyster Point Blvd., Suite 505 So. San Francisco CA 94080 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-09 | 100,000 | $0.48 | 0 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-10-10 | 24,000 | $0.49 | 0 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-10-13 | 92,000 | $0.47 | 356,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 300,757 | Indirect | By Family Trust |
Footnotes
- Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.468 to $0.49. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.463 to $0.485. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Does not include 10,000 shares held by his adult son.
- The reporting person is the trustee of the family trust owning the indicated shares.
Billionaire Hedge Funds
